The findings suggest that analyzing ErbB receptor signaling characteristics may provide predictive information and that simultaneous targeting of EGFR and other ErbB family members may reduce HNSCC cell proliferation (Table 1). Here, EGFR is linked to head and neck squamous cell carcinoma.